Ignite Creation Date:
2025-12-25 @ 3:08 AM
Ignite Modification Date:
2026-06-02 @ 2:05 PM
Study NCT ID:
NCT01520805
Status:
WITHDRAWN
Last Update Posted:
2016-12-29
First Post:
2012-01-20
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Effectiveness Study of CPI-613 to Treat Refractory or Relapsed Leukemia and Myelodysplastic Syndrome
Sponsor:
Cornerstone Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CL-CPI-613-022
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None